References
- World Health Organization. World Malaria Report . WHO Press, Geneva, Switzerland (2011).
- World Health Organization. Guidelines for the Treatment of Malaria (2nd Edition). WHO Press, Geneva, Switzerland (2010).
- Hastings IM, Watkins WM, White NJ. The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos. Trans. R. Soc. Lond. B Biol. Sci. 357(1420), 505–519 (2002).
- Hastings IM, Watkins WM. Tolerance is the key to understanding antimalarial drug resistance. Trends Parasitol. 22(2), 71–77 (2006).
- Miller LH, Su X. Artemisinin: discovery from the Chinese herbal garden. Cell 146(6), 855–858 (2011).
- Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat. Med. 17(10), 1217–1220 (2011).
- Liu R, Dong HF, Jiang MS. Artemisinin: the gifts from traditional Chinese medicine not only for malaria control but also for schistosomiasis control. Parasitol. Res. 110(5), 2071–2074 (2012).
- Eastman RT, Fidock DA. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat. Rev. Microbiol. 7(12), 864–874 (2009).
- Hombhanje FW, Linge D, Saweri A et al. Artemisinin–naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy. Malar. J. 8, 196 (2009).
- Tun T, Tint HS, Lin K et al. Efficacy of oral single dose therapy with artemisinin–naphthoquine phosphate in uncomplicated falciparum malaria. Acta Trop. 111(3), 275–278 (2009).
- Hombhanje FW, Huang QY. Artemisinin–naphthoquine combination (ARCO®): an overview of progress. Pharmaceuticals 3, 3581–3593 (2010).
- Batty KT, Salman S, Moore BR et al. Artemisinin–naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study. Antimicrob. Agents Chemother. 56(5), 2472–2484 (2012).
- Benjamin J, Moore B, Lee ST et al. Artemisinin–naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study. Antimicrob. Agents Chemother. 56(5), 2465–2471 (2012).
- Davis TM, England M, Dunlop AM et al. Assessment of the effect of mefloquine on artesunate pharmacokinetics in healthy male volunteers. Antimicrob. Agents Chemother. 51(3), 1099–1101 (2007).
- Karunajeewa HA, Ilett KF, Mueller I et al. Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. Antimicrob. Agents Chemother. 52(1), 237–243 (2008).
- Manning L, Laman M, Page-Sharp M et al. Meningeal inflammation increases artemether concentrations in cerebrospinal fluid in Papua New Guinean children treated with intramuscular artemether. Antimicrob. Agents Chemother. 55(11), 5027–5033 (2011).
- Qu HY, Gao HZ, Hao GT et al. Single-dose safety, pharmacokinetics, and food effects studies of compound naphthoquine phosphate tablets in healthy volunteers. J. Clin. Pharmacol. 50(11), 1310–1318 (2010).
- Wang JY, Cao WC, Shan CQ et al. Naphthoquine phosphate and its combination with artemisinine. Acta Trop. 89(3), 375–381 (2004).
- Martinelli A, Moreira R, Ravo PV. Malaria combination therapies: advantages and shortcomings. Mini Rev. Med. Chem. 8(3), 201–212 (2008).
- Borrmann S, Sasi P, Mwai L et al. Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. PLoS ONE 6(11), e26005 (2011).